Bathi operasional EBITDA: elevaiskincare.com (ELAB)

Elevai Labs Inc. (ELAB) is creating a closed aesthetic medicine ecosystem by connecting physicians and patients through exosome-based beauty solutions. The EBITDA_Co trend clearly demonstrates the inflow of capital into the business, while 0.00 captures the current value of the indicator. The company is actively scaling its line of restorative skin rejuvenation products. Simultaneously, it is implementing ESG standards, including the elimination of microplastics and the use of recycled packaging.

The implementation of ESG standards in skin regeneration biotechnology minimizes waste disposal costs, which directly impacts the calculated value of 0.00. This metric strips the operating cash flow of non-cash charges and accounting adjustments, reflecting the business's actual ability to generate liquidity to cover liabilities, which clearly confirms the absolute EBITDA trend for Elevai Labs Inc. (ELAB).